Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose-response. [PDF]
de Groot ADE +5 more
europepmc +1 more source
Letter to the Editor in response to: "ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis". [PDF]
Pepe A, Mandato C.
europepmc +1 more source
Odevixibat therapy in progressive familial intrahepatic cholestasis with MYO5B variants: a retrospective case series. [PDF]
Roquelaure B +8 more
europepmc +1 more source
Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2. [PDF]
Lapalus M +12 more
europepmc +1 more source
Immunohistochemistry in Progressive Familial Intrahepatic Cholestasis (PFIC): Bridging Gap Between Morphology and Genetics. [PDF]
Nigam N +5 more
europepmc +1 more source
Response to "Letter to the Editor in response to: 'ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis'". [PDF]
Dalal BS.
europepmc +1 more source
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis. [PDF]
Di Giorgio A +15 more
europepmc +1 more source
A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis. [PDF]
Behrendt A +16 more
europepmc +1 more source
ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis. [PDF]
Ben Sabbahia D +4 more
europepmc +1 more source

